Survival
tumor
TUMOR
No significant difference was seen in 3-year survival between both groups. Three-year survival was 57.1% in the open group versus 46.8% in the minimally invasive group, regardless of more N3 patients in the MITG group (Survival curves corrected for ASA classification, age, pathological tumor, and node stage